Invesaro

Stocks Health care CLNN

NASDAQ · Health care

Clene Inc. (CLNN)

Clene Inc. brought in $197K of revenue over the twelve months to June 30, 2026, down 31.1% from a year earlier. It posted a net loss of $39.5M. In fiscal 2025 capital spending exceeded operating cash flow by $18.6M. At June 30, 2026 it held $9.7M in cash against $17.6M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.

Price
$4.30
+2.14% on the day · September 25, 2026
52-week range $3.25 to $13.50
Market cap
$55.2M
Revenue (last 12 months)
$197K
-31.1% year on year
Net margin
-20,059.9%

What Clene Inc. does

Clene Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker CLNN.

Revenue and profit by year

Revenue
FY20: $206K $206K FY20FY21: $723K $723K FY21FY22: $473K $473K FY22FY23: $654K $654K FY23FY24: $342K $342K FY24FY25: $200K $200K FY25
Net income
FY20: -$16.2M -$16.2M FY20FY20: -$19.3M -$19.3M FY20FY21: -$9.7M -$9.7M FY21FY22: -$29.9M -$29.9M FY22FY23: -$49.5M -$49.5M FY23FY24: -$39.4M -$39.4M FY24FY25: -$26.2M -$26.2M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$200K-$23.1M-$26.2M-$2.65-$18.6M
2024$342K-$33.1M-$39.4M-$5.67-$21.3M
2023$654K-$40.5M-$49.5M-$9.43-$30.5M
2022$473K-$48.4M-$29.9M-$9.23-$44.2M
2021$723K-$50M-$9.7M-$3.21-$36M
2020$206K-$20.2M-$19.3M-$22.07-$19.3M

Latest SEC filings

What Clene Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 16, 2026
  2. September 16, 2026
  3. August 14, 2026
  4. August 14, 2026
  5. August 14, 2026
    Quarterly report 10-Q · period to June 30, 2026
  6. August 11, 2026
  7. August 10, 2026
  8. August 4, 2026
  9. June 5, 2026
  10. May 22, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 18, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about CLNN

What does Clene Inc. do?

Clene Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker CLNN.

Is Clene Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $39.5M on revenue of $197K.

How much revenue does Clene Inc. make?

Over the twelve months to June 30, 2026 Clene Inc. reported revenue of $197K. That is 31.1% less than a year earlier.

When did Clene Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 18, 2026.

Similar companies

Follow CLNN

Get an email when Clene Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow CLNN: get an email when it files

Where the numbers come from

Financial figures are the values Clene Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.